Prognostic value of an index for serum globulin compensation in colon and breast cancers

Singapore Medical Journal

Volumn 46, Issue 12, 2005, Pages 710-713

  Al Joudi, Fawwaz Shakir ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Breast cancer; Colon cancer; Globulin compensation index; Serum albumin; Serum globulin

Indexed keywords

ALBUMIN; GLOBULIN; PLASMA PROTEIN;

ALBUMIN BLOOD LEVEL; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CHRONIC DISEASE; COLON CANCER; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; PROGNOSIS; PROTEIN BLOOD LEVEL; SERUM;

BREAST NEOPLASMS; COLONIC NEOPLASMS; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SERUM ALBUMIN; SERUM GLOBULINS;

EID: 28844473563     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997; 50:693-703.
2. Feldman JG, Burns DN, Gange SJ, et al. Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study. AIDS 2000; 14:863-70.
3. Reuben DB, Ferrucci L, Wallace R, et al. The prognostic value of serum albumin in healthy older persons with low and high serum interleukin-6 (IL-6) levels. J Am Geriatr Soc 2000; 48:1404-7.
4. Corti MC, Guralnik JM, Salive ME, et al. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA 1994; 272:1036-42.
5. Rzany B, Partscht K, Jung M, et al. Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. Arch Dermatol 2002; 138:903-8.
6. Chao FC, Efron B, Wolf P. The possible prognostic usefulness of assessing serum proteins and cholesterol in malignancy. Cancer 1975; 35:1223-9.
7. O'Gorman P, McMillan DC, Mc Ardle CS. Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer. Nutr Cancer 1999; 35:127-9.
8. Bremnes RM, Bremnes Y, Donnem T. High-grade non-Hodgkin's lymphoma treated in northern Norway: treatment, outcome and prognostic factors. Acta Oncol 1999; 38:117-24.
9. Maltoni M, Amadori, D. Prognosis in advanced cancer. Hematol Oncol Clin North Am 2002; 16:715-29.
10. Dumontet C, Mounier N, Munck JN, et al. Factors predictive of early death in patients receiving high-dose CHOP (ACVB regimen) for aggressive non-Hodgkin's lymphoma: a GELA study. Br J Haematol 2002; 118:210-7.
11. Wang JY, Chen KY, Wang JT, et al. Outcome and prognostic factors for patients with non-small-cell lung cancer and severe radiation pneumonitis. Int J Radiat Oncol Biol Phys 2002; 54:735-41.
12. Smaletz O, Scher HI, Small EJ, et al. Normogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol 2002; 20:3972-82.
13. Fujishiro M, Okada S, Ueno H, et al. Predictive factors for tumor response to chemotherapy in patients with pancreatic cancer. Hepatogastroenterology 2000; 47:1744-6.
14. Schwartzbaum JA, Lal P, Evanoff W, et al. Presurgical serum albumin levels predict survival time from glioblastoma multiforme. J Neurooncol 1999; 43:35-41.
15. Walsh D, Mahmoud F, Barna B. Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Support Care Cancer 2003; 11:60-2.
16. Pisters PW, Brennen MF. Amino acid metabolism in human cancer cachexia. Annu Rev Nutr 1990; 10:107-32.
17. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 2002; 52:72-91.
18. Al-Joudi FS, Wahab NA. The utilization of an index for serum globulin compensation in diseases associated with decreased serum albumin. Med J Malaysia 2004; 59:495-501.
19. Henry JB, ed. Clinical Diagnosis and Management by Laboratory Methods. 19th ed. Philadelphia: WB Saunders, 1996.
20. Era S, Kuwata K, Imai H, et al. Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1995; 1247:12-6.
21. Kaufmann MA, Castelli I, Pargger H, et al. Nitric oxide dose-response study in isolated perfused rat kidney after inhibition of endothelium-derived relaxing factor synthesis: the role of serum albumin. J Pharmacol Exp Ther 1995; 273:855-62.
22. Zoellner H, Hofler M, Beckmann R, et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci 1996; 109 (Pt 10):2571-80.
23. Barber MD, Fearon KC, McMillan DC, et al. Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients. Am J Physiol Endocrinol Metab 2000; 279:E707-14.
24. Koretz RL. Intravenous albumin and nutrition support: going for the quick fix. JPEN J Patenter Enteral Nutr, 1995; 19:166-71.
25. Reuben DB, Mor V, Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 1988; 148:1586-91.
26. Morris JC, Holland JF. Oncologic emergencies. In: Holland JF, Frei E III, Bast RC Jr, Kufe DW, Monton DL, Weichselbaum RR, eds. Cancer Medicine. Vol 2. 3rd ed. Philadelphia: Lea and Febiger, 1993.